Skip to content

The application of tunneled femoral inserted central catheter for cancer patients

The application of tunneled femoral inserted central catheter for cancer patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055864
Enrollment
Unknown
Registered
2022-01-21
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

Inserted PICCs Group:None

Sponsors

Sun Yat-sen University Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 75 years; Education level: primary school education or above, with certain listening, speaking, reading, and writing skills, and able to fill out the measurement questionnaire independently; 2. The patient is unable to indwell the venous access of the upper extremity due to the disease, and needs to place a PICC catheter through the inferior cavity; 3. After PICC cannulation can still be maintained in our hospital on time; 4. Those who voluntarily participated in this study and signed the informed consent for this study and the PICC placement.

Exclusion criteria

Exclusion criteria: 1. Those with known or suspected signs of infection, bacteremia or sepsis related to catheterization; 2. Patients with a history of radiotherapy, vascular surgery, venous thrombosis, or swelling of the limbs in the catheter placement route; 3. Those who used anticoagulant drugs such as warfarin, heparin, and urokinase within three days before catheteration; 4. Patients with severe bleeding disorders and severe coagulation dysfunction (platelets < 2x10^9/L, white blood cells < 1.5x10^9/L); other catheters on the puncture side; 5. Known or suspected allergy to the components contained in the PICC catheter patients; language communication disorders, patients with senile dementia, severe heart, liver, kidney and nervous system diseases.

Design outcomes

Primary

MeasureTime frame
thrombosis;occlusion;unplanned extubation;patients‘ experience;

Countries

China

Contacts

Public ContactHuang Chunli

Sun Yat-sen University Cancer Center

haungchunl@sysucc.org.cn+86 1892519118

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026